Add-on Acquisition • Medical Products

Abattis Bioceuticals Acquires Green Tree Therapeutics

On January 11, 2018, Abattis Bioceuticals acquired medical products company Green Tree Therapeutics

Acquisition Context
  • This is Abattis Bioceuticals’ 1st transaction in the Medical Products sector.
  • This is Abattis Bioceuticals’ 1st transaction in Canada.
  • This is Abattis Bioceuticals’ 1st transaction in British Columbia.

Explore All 2734 Add-on Acquisition Medical Products Deals - Search the Database Free


M&A Deal Summary

Date January 11, 2018
Target Green Tree Therapeutics
Sector Medical Products
Buyer(s) Abattis Bioceuticals
Deal Type Add-on Acquisition

Target Company

Green Tree Therapeutics

Vancouver, British Columbia, Canada
Green Tree Therapeutics Corp. is focused on designing and selling branded cannabis products. Green Tree Therapeutics is based in Vancouver, British Columbia.
Explore More Deals

Browse All 215,262 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Abattis Bioceuticals

Langley, British Columbia, Canada

Category Company
Sector Life Science
DESCRIPTION

Abattis Bioceuticals Corp. is a life sciences and biotechnology company which aggregates, integrates, and invests in cannabis technologies and biotechnology services for the legal cannabis industry developing in Canada.


Deal Context for Buyer #
Overall 1 of 4
Sector: Medical Products 1 of 2
Type: Add-on Acquisition 1 of 3
State: British Columbia 1 of 2
Country: Canada 1 of 2
Year: 2018 1 of 3
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-02-01 CannaNUMUS Blockchain

United States

CannaNUMUS Blockchain, Inc. is a developer of cryptocurrency.

Buy -